---
title: "WHWK.US (WHWK.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WHWK.US/news.md"
symbol: "WHWK.US"
name: "WHWK.US"
parent: "https://longbridge.com/en/quote/WHWK.US.md"
datetime: "2026-03-04T13:08:35.569Z"
locales:
  - [en](https://longbridge.com/en/quote/WHWK.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WHWK.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WHWK.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/WHWK.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/WHWK.US/news.md)


# WHWK.US (WHWK.US) — Related News

### [Aadi Bioscience Conference: Whitehawk CEO Details 3-Program ADC Pipeline, First Data Seen in 2027](https://longbridge.com/en/news/277665104.md)
*2026-03-03T18:30:25.000Z*
> Whitehawk Therapeutics CEO Dave Lennon presented at TD Cowen’s 46th Annual Healthcare Conference, detailing the company'

### [Whitehawk Therapeutics (Nasdaq: WHWK) will present at investor conferences as a clinical-stage oncology company.](https://longbridge.com/en/news/277047766.md)
*2026-02-26T13:01:37.000Z*
> On February 26, 2026, in Morristown, New Jersey, Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a company in the clinical-

### [Aadi Bioscience Conference: CEO Spotlights Whitehawk ADC Pipeline, Cash Runway Through 2028](https://longbridge.com/en/news/276929771.md)
*2026-02-25T19:21:25.000Z*
> Whitehawk Therapeutics CEO Dave Lennon presented the company's ADC strategy at the Aadi Bioscience Conference, highlight

### [Whitehawk Therapeutics Advances To Clinical Stage With Ind Clearance For Hwk-007](https://longbridge.com/en/news/271942249.md)
*2026-01-08T13:40:54.000Z*
> Jan 8 (Reuters) - Whitehawk Therapeutics Inc:* WHITEHAWK THERAPEUTICS ADVANCES TO CLINICAL STAGE WITH IND CLEARANCE FOR 

### [Whitehawk Therapeutics Unveils ADC Pipeline and Platform Innovations in Corporate Presentation](https://longbridge.com/en/news/271941038.md)
*2026-01-08T13:33:13.000Z*
> Whitehawk Therapeutics Inc. has unveiled its differentiated antibody-drug conjugate (ADC) platform in a corporate presen

### [FDA Clears Whitehawk Therapeutics' IND Application for HWK-007](https://longbridge.com/en/news/271936626.md)
*2026-01-08T13:02:25.000Z*
> Whitehawk Therapeutics Inc. has received FDA clearance for its IND application for HWK-007, a PTK7-targeted antibody-dru

### [Whitehawk Therapeutics (NASDAQ:WHWK) Now Covered by Jones Trading](https://longbridge.com/en/news/270526873.md)
*2025-12-22T19:00:32.000Z*
> Jones Trading initiated coverage on Whitehawk Therapeutics with a "buy" rating and a $7.00 price target, suggesting a po

### [Whitehawk Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Medical Officer Margaret Dugan](https://longbridge.com/en/news/268315732.md)
*2025-12-02T21:46:59.000Z*
> Whitehawk Therapeutics Inc. has filed Form 3, identifying Chief Medical Officer Margaret Dugan as a beneficial owner. Th

### [Whitehawk Therapeutics Names Margaret Dugan as Chief Medical Officer](https://longbridge.com/en/news/268090968.md)
*2025-12-01T13:01:41.000Z*
> Whitehawk Therapeutics Inc. has appointed Dr. Margaret Dugan as Chief Medical Officer. With over 30 years of experience